Efficacy and safety of GR1802 in uncontrolled CRSwNP: placebo-controlled phase 2 trial.
Zheng M, Wu D, Piao Y, Tang J, Quan F, Guan B, Yu H, Zhang X, He G, Yang Y, Wan L, Li X, Liu W, Xu Z, Ye J, Liu W, Song X, Du Y, Xu Y, Chen J, Wang W, Lan F, Wang C, Zhang L.
Zheng M, et al. Among authors: wang w.
J Allergy Clin Immunol. 2025 Feb 7:S0091-6749(25)00126-5. doi: 10.1016/j.jaci.2025.01.034. Online ahead of print.
J Allergy Clin Immunol. 2025.
PMID: 39924121